Compare AstraZeneca plc (AZN) vs Teradyne, Inc. (TER) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AstraZeneca plc vs Teradyne, Inc. — how do they compare? AstraZeneca plc trades at $158.03 (market cap $248.14B), while Teradyne, Inc. trades at $390.66 (market cap $59.34B). The key difference: AstraZeneca plc is far larger — about 4.2× Teradyne, Inc.'s market cap, and AstraZeneca plc pays the higher dividend (2.01%). Which is the better fit depends on your goals.
| AZN | TER | |
|---|---|---|
Market Cap | $248.14B | $59.34B |
Sector | Health | Technology |
52-Week High | $209.48 | $483.84 |
52-Week Low | $147.06 | $109.30 |
Enterprise Value | $275.41B | $59.09B |
Dividend Yield | 2.01% | 0.14% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AstraZeneca plc
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →About Teradyne, Inc.
Teradyne provides testing equipment, including automated test equipment for semiconductors, system testing for hard disk drives, circuit boards, and electronics systems and wireless testing for devices. The firm entered the industrial automation market in 2015, into which it sells collaborative and autonomous robots for factory applications. Teradyne serves numerous end markets and geographies directly and indirectly with its products, but its most significant exposure is to semiconductor testing, which made up 71% of 2021 sales. Teradyne serves vertically integrated, fabless, and foundry chipmakers with its equipment.
Read more on TER →
